Business Context and Reporting Period
Company: MagnaChip Semiconductor Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: July 27, 2011
Reporting Period: Second quarter ended June 30, 2011
This filing serves to announce the results of operations and financial condition for the second quarter of 2011. The detailed financial data is contained in a press release dated July 27, 2011, attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing explicitly states that financial information regarding revenue, profit, cash flow, margins, debt, and liquidity is located in the attached press release (Exhibit 99.1). Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only references the existence of the second-quarter results in the attached exhibit.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release containing management's discussion of the second-quarter results.
Legal Disclaimer: The information disclosed under Item 2.02, including the attached press release, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, except as expressly set forth by specific reference.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 27, 2011) for actual revenue, net income, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Confirm any forward-looking guidance or outlook statements provided in the press release.
- Note that the financial data in this filing is not deemed "filed" under Section 18 of the Exchange Act unless specifically referenced in other filings.